ncRNA name
LINC01198
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
Yes
Biomarker application
Upstream regulatory factors
Not available
Downstream target
NEDD4-1/PTEN
Cancer name
Glioma
Cancer site
Brain, Central Nervous System
Treatment type
Chemotherapy
Drug
Temozolomide
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
40
Male patients
22
Female patients
18
Age range and number
Not available
PMID
Description
We showed that LINC01198 exerted its oncogenic activities by enhancing the NEDD4-1-dependent repression of PTEN.
Tissue resource
glioma tissues and adjacent tissues
human glioma cell lines U87
human glioma cell lines U251
human glioma cell lines SHG-44
human glioma cell lines SNB-19
human glioma cell lines LN229
human glioma cell lines T98G
Experiment
qRT-PCR,Western blot
Institute
the Renji Hospital
American Type Culture Collection
Country
China
USA
Continent
Asia
North American